Optimally controlled treatment strategy using interferon and ribavirin for hepatitis C
From MaRDI portal
Publication:3465764
DOI10.1142/S0218339009002727zbMATH Open1369.92052OpenAlexW2111060475MaRDI QIDQ3465764FDOQ3465764
Authors: Siddhartha P. Chakrabarty, Hem Raj Joshi
Publication date: 22 January 2016
Published in: Journal of Biological Systems (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1142/s0218339009002727
Recommendations
- Dynamical analysis of a class of hepatitis C virus infection models with application of optimal control
- scientific article; zbMATH DE number 5619922
- Dynamics of hepatitis C viral load with optimal control treatment strategy
- Optimal antiviral treatment strategies of HBV infection model with logistic hepatocyte growth
- Mathematical modeling of transmission dynamics and optimal control of vaccination and treatment for hepatitis B virus
Medical applications (general) (92C50) Medical epidemiology (92C60) Applications of optimal control and differential games (49N90)
Cites Work
Cited In (9)
- Global dynamics for a live-virus-blood model with distributed time delay
- Evaluating treatment of hepatitis C for hemolytic anemia management
- Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model
- A minimum principle for stochastic control of hepatitis C epidemic model
- Observer‐based controller for treatment of hepatitis C infection using fractional order model
- Dynamical analysis of a class of hepatitis C virus infection models with application of optimal control
- Influence of intracellular delay on the dynamics of Hepatitis C virus
- Global dynamics of hepatitis C viral infection with logistic proliferation
- Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin
This page was built for publication: Optimally controlled treatment strategy using interferon and ribavirin for hepatitis C
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3465764)